Alumis Inc.

US$6.03As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:ALMSHealthcare
Country USA
PE (Fwd) •••
TSR 2Y CAGR (28.51%)
Div yield —
ROE (93.65%)
Biotechnology
Beta (5Y) (0.27)
PE TTM —
TSR TTM 26.95%
Mkt cap US$780.5M
ROIC (52.46%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$6.82
13.12%
(84.97%)
Hold 0|10|6|2|4
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.09
0.09
0.09
0.09
20.82%
16.52%
14.58%
2.64%
Revenue$M
59.96
58.69
60.15
58.68
15.39%
8.61%
5.62%
(1.75%)
Peers (US$780.5M)
Cap (US$)
PE
796.2M
—
760.3M
—
Capital
TTM
5Y
10Y
Leveragex
0.662
(0.441)
(0.325)
EBIT/Intx
0.314
1.435
1.327
Own earn%
(88.43)
22.95
21.12
Sh yield%
27.46
31.44
32.29
Owners
Insiders/Inst%
10.97
25.89
Short interest%
0.77
SBC / revenue%
3.41
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
18
Op margin range%
11–15
$1 testx
—
Incr. ROIC%
1